{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:21:32Z","timestamp":1777083692596,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.arbres.2014.02.004","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T20:39:27Z","timestamp":1396039167000},"page":"392-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Diagn\u00f3stico y tratamiento de los tumores pulmonares neuroendocrinos"],"prefix":"10.1016","volume":"50","author":[{"given":"Julio","family":"S\u00e1nchez de Cos Escu\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2014.02.004_bib0005","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Carcinoids tumors","volume":"340","author":"Kulke","year":"1999","journal-title":"N Eng J Med"},{"key":"10.1016\/j.arbres.2014.02.004_bib0010","series-title":"Lung Cancer. Principles and Practice.","first-page":"971","article-title":"The spectrum of carcinoids tumors","author":"Kosmidis","year":"2010"},{"key":"10.1016\/j.arbres.2014.02.004_bib0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.5858\/2009-0583-RAR.1","article-title":"Neuroendocrine tumors of the lung. An update","volume":"134","author":"Rekhtman","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.arbres.2014.02.004_bib0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ctrv.2012.06.012","article-title":"Treatment of pulmonary neuroendocrine tumors: State of the art and future developments","volume":"39","author":"Gridelli","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.arbres.2014.02.004_bib0025","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/JTO.0b013e3181861d7b","article-title":"Proceedings of the IASLC International workshop on advances in pulmonary neuroendocrine tumors 2007","volume":"3","author":"Lim","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0030","series-title":"Pathology & Genetics. Tumors of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"key":"10.1016\/j.arbres.2014.02.004_bib0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/JTO.0b013e318197f2e7","article-title":"Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids","volume":"4","author":"Ferolla","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"Suppl 7","key":"10.1016\/j.arbres.2014.02.004_bib0040","first-page":"vii65","article-title":"Advances in neuroendocrine lung tumors","author":"Travis","year":"2010","journal-title":"Ann Oncol 2010"},{"key":"10.1016\/j.arbres.2014.02.004_bib0045","doi-asserted-by":"crossref","first-page":"8874","DOI":"10.1200\/JCO.2005.02.8233","article-title":"Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRa, PDGFRb and Met in large-cell neuroendocrine carcinoma of the lung","volume":"23","author":"Rossi","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0050","series-title":"Lung Cancer. Principles and Practice","first-page":"341","article-title":"Clinical presentation of small cell lung cancer","author":"Masters","year":"2010"},{"key":"10.1016\/j.arbres.2014.02.004_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcts.2007.01.075","article-title":"ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer","volume":"32","author":"De Leyn","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.arbres.2014.02.004_bib0060","first-page":"454","article-title":"Normativa SEPAR sobre estadificaci\u00f3n del c\u00e1ncer de pulm\u00f3n","volume":"47","author":"S\u00e1nchez de Cos","year":"2011","journal-title":"Arch Bronchoneumol"},{"issue":"Suppl III","key":"10.1016\/j.arbres.2014.02.004_bib0065","first-page":"1","article-title":"Guidelines on the radical management of patients with lung cancer","volume":"65","author":"Lim","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2014.02.004_bib0070","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2967\/jnumed.109.066639","article-title":"A comparison of 68Ga-DOTATATE and 18F-FDG PET\/CT in pulmonary neuroendocrine tumors","volume":"50","author":"Kayani","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.arbres.2014.02.004_bib0075","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/JTO.0b013e31815bdc0d","article-title":"The International Association for the Study of Lung Cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer","volume":"2","author":"Shepherd","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0080","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/JTO.0b013e31818b06e3","article-title":"The IASLC Lung Cancer Staging project: Proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for lung cancer","volume":"3","author":"Travis","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/JTO.0b013e318194a355","article-title":"The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th edition","volume":"4","author":"Ignatius Ou","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0090","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/JTO.0b013e3181b27799","article-title":"Proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer","volume":"4","author":"Valli\u00e8res","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0095","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/JTO.0b013e31829f097a","article-title":"Outcome and prognostic factors in bronchial carcinoids. A single center experience","volume":"8","author":"Filosso","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0003-4975(00)01369-2","article-title":"Prognostic factors in neuroendocrine lung tumors: A Spanish multicenter study","volume":"70","author":"Garc\u00eda-Yuste","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.arbres.2014.02.004_bib0105","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejcts.2006.11.031","article-title":"Typical and atypical carcinoid tumours: Analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung","volume":"31","author":"Garc\u00eda-Yuste","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.arbres.2014.02.004_bib0110","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/hupa.2000.19294","article-title":"Pulmonary atypical carcinoids: Predictors of survival in 106 cases","volume":"31","author":"Beasley","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/JTO.0b013e31816de2b8","article-title":"The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition","volume":"3","author":"Sculier","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1378\/chest.119.4.1143","article-title":"Typical and atypical pulmonary carcinoids: Outcome in patients presenting with regional lymph node involvement","volume":"119","author":"Thomas","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2014.02.004_bib0125","unstructured":"National Cancer Comprehensive Center \u2014 Clinical practice guidelines in Oncology \u2014 Small cell lung cancer. Version 2.2013 [consultado 12 Ago 2013]. Disponible en: http:\/\/www,nccn.org"},{"key":"10.1016\/j.arbres.2014.02.004_bib0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lungcan.2003.11.016","article-title":"Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy","volume":"44","author":"Wirtz","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.arbres.2014.02.004_bib0135","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(11)61742-X","article-title":"Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): A randomised, placebo-controlled, phase 3 study","volume":"378","author":"Pavel","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2014.02.004_bib0140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/bjs.4149","article-title":"Randomized clinical trial of the effect of interferon \u03b1 on survival in patients with disseminated midgut carcinoid tumours","volume":"90","author":"K\u00f6lby","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.arbres.2014.02.004_bib0145","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.2007.13.6374","article-title":"Targeting vascular endothelial growth factor in advanced carcinoid tumor: A random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2 beta","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0150","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/JTO.0b013e318189f551","article-title":"The prognostic and predicitive role of histology in advanced non-small cell lung cancer","volume":"3","author":"Hirsch","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0155","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jtcvs.2008.12.037","article-title":"Postoperative recurrence and the role of adjuvanrt chemotherapy in patients with pulmonary large cell carcinoma","volume":"138","author":"Iyoda","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.arbres.2014.02.004_bib0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.lungcan.2005.01.008","article-title":"Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy","volume":"49","author":"Yamakazi","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.arbres.2014.02.004_bib0165","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.lungcan.2011.08.012","article-title":"Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens","volume":"75","author":"Shimada","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.arbres.2014.02.004_bib0170","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.lungcan.2012.04.009","article-title":"Chemotherapy for pulmonary large-cell neuroendocrine carcinoma: Similar to that for small cell lung cancer or non-small cell lung cancer?","volume":"77","author":"Sun","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.arbres.2014.02.004_bib0175","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/JTO.0b013e31828f6989","article-title":"Combination chemotherapy with irinotecan and cisplatin for large-cell neuroencocrine carcinoma of the lung. A multicenter phase II study","volume":"10","author":"Niho","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.arbres.2014.02.004_bib0180","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1200\/JCO.2011.36.2251","article-title":"Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib","volume":"29","author":"De Pas","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.arbres.2014.02.004_bib0185","doi-asserted-by":"crossref","first-page":"e400S","DOI":"10.1378\/chest.12-2363","article-title":"Treatment of small cell lung cancer diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Jett","year":"2013","journal-title":"Chest"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289614000775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289614000775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:59:07Z","timestamp":1648706347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289614000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0300289614000775"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2014.02.004","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagn\u00f3stico y tratamiento de los tumores pulmonares neuroendocrinos","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2014.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 SEPAR. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}